ETNB
Price
$8.20
Change
+$0.40 (+5.13%)
Updated
May 14 closing price
Capitalization
1.2B
84 days until earnings call
SNDX
Price
$9.28
Change
-$0.91 (-8.93%)
Updated
May 14 closing price
Capitalization
798.52M
88 days until earnings call
Ad is loading...

ETNB vs SNDX

Header iconETNB vs SNDX Comparison
Open Charts ETNB vs SNDXBanner chart's image
89bio
Price$8.20
Change+$0.40 (+5.13%)
Volume$2.53M
Capitalization1.2B
Syndax Pharmaceuticals
Price$9.28
Change-$0.91 (-8.93%)
Volume$3.26M
Capitalization798.52M
ETNB vs SNDX Comparison Chart
Loading...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ETNB vs. SNDX commentary
May 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETNB is a StrongBuy and SNDX is a Hold.

Ad is loading...
COMPARISON
Comparison
May 15, 2025
Stock price -- (ETNB: $8.20 vs. SNDX: $9.28)
Brand notoriety: ETNB and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETNB: 128% vs. SNDX: 148%
Market capitalization -- ETNB: $1.2B vs. SNDX: $798.52M
ETNB [@Biotechnology] is valued at $1.2B. SNDX’s [@Biotechnology] market capitalization is $798.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $289.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETNB’s FA Score shows that 1 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • ETNB’s FA Score: 1 green, 4 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, ETNB is a better buy in the long-term than SNDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETNB’s TA Score shows that 6 TA indicator(s) are bullish while SNDX’s TA Score has 5 bullish TA indicator(s).

  • ETNB’s TA Score: 6 bullish, 5 bearish.
  • SNDX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ETNB is a better buy in the short-term than SNDX.

Price Growth

ETNB (@Biotechnology) experienced а +6.91% price change this week, while SNDX (@Biotechnology) price change was -7.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.30%. For the same industry, the average monthly price growth was +5.09%, and the average quarterly price growth was -6.29%.

Reported Earning Dates

ETNB is expected to report earnings on Aug 07, 2025.

SNDX is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-0.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETNB($1.2B) has a higher market cap than SNDX($799M). ETNB YTD gains are higher at: 4.859 vs. SNDX (-29.803). SNDX has higher annual earnings (EBITDA): -318.27M vs. ETNB (-380.21M). ETNB has more cash in the bank: 639M vs. SNDX (516M). SNDX has less debt than ETNB: SNDX (1.84M) vs ETNB (37.6M). SNDX has higher revenues than ETNB: SNDX (43.7M) vs ETNB (0).
ETNBSNDXETNB / SNDX
Capitalization1.2B799M150%
EBITDA-380.21M-318.27M119%
Gain YTD4.859-29.803-16%
P/E RatioN/AN/A-
Revenue043.7M-
Total Cash639M516M124%
Total Debt37.6M1.84M2,047%
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ETNBSNDX
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 13 days ago
85%
Bullish Trend 15 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 8 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGIFX40.81N/A
N/A
American Funds Intl Gr and Inc F1
RDLAX10.59N/A
N/A
Columbia Disciplined Growth A
USAAX38.29N/A
N/A
Victory Growth
GITIX36.51N/A
N/A
Goldman Sachs Technology Opps Inst
STSVX17.96N/A
N/A
BNY Mellon Sm Cp Val I

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
+5.13%
AKRO - ETNB
59%
Loosely correlated
-5.32%
RCKT - ETNB
56%
Loosely correlated
-8.47%
IDYA - ETNB
55%
Loosely correlated
-2.01%
CRNX - ETNB
53%
Loosely correlated
+1.10%
COGT - ETNB
52%
Loosely correlated
-2.20%
More